ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for prostate cancer treatment, has announced its participation in the 2024 Cantor Global Healthcare Conference. The company will present on September 18, 2024, at 9:10 a.m. ET in New York, NY.
Key executives participating in a fireside chat include David R. Parkinson (President and CEO), Peter Virsik (COO and EVP), and David S. Wood (CFO). A live webcast of the event will be available on ESSA's website in the Investors/Events & Presentations section, and will remain archived for 90 days post-event.
ESSA Pharma (NASDAQ: EPIX), un'azienda farmaceutica in fase clinica focalizzata su sviluppare nuove terapie per il trattamento del cancro alla prostata, ha annunciato la sua partecipazione alla Conferenza Globale sulla Salute Cantor 2024. L'azienda presenterà il 18 settembre 2024, alle 9:10 a.m. ET a New York, NY.
I principali dirigenti che parteciperanno a una conversazione informale includono David R. Parkinson (Presidente e CEO), Peter Virsik (COO ed EVP) e David S. Wood (CFO). Una trasmissione in diretta dell'evento sarà disponibile sul sito web di ESSA nella sezione Investitori/Eventi e Presentazioni e verrà archiviata per 90 giorni dopo l'evento.
ESSA Pharma (NASDAQ: EPIX), una empresa farmacéutica en etapa clínica centrada en desarrollar nuevas terapias para el tratamiento del cáncer de próstata, ha anunciado su participación en la Conferencia Global de Salud Cantor 2024. La empresa presentará el 18 de septiembre de 2024, a las 9:10 a.m. ET en Nueva York, NY.
Los principales ejecutivos que participarán en una charla informal incluyen a David R. Parkinson (Presidente y CEO), Peter Virsik (COO y EVP) y David S. Wood (CFO). Una transmisión en vivo del evento estará disponible en el sitio web de ESSA en la sección de Inversores/Eventos y Presentaciones, y permanecerá archivada durante 90 días después del evento.
ESSA Pharma (NASDAQ: EPIX)는 전립선암 치료를 위한 새로운 치료법 개발에 중점을 둔 임상 단계의 제약 회사로, 2024 칸토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사는 2024년 9월 18일 오전 9시 10분 ET에 뉴욕에서 발표할 예정입니다.
비공식 대화에 참가하는 주요 경영진으로는 David R. Parkinson (회장 및 CEO), Peter Virsik (COO 및 EVP), David S. Wood (CFO)가 있습니다. 실시간 웹캐스트는 ESSA의 웹사이트 투자자/이벤트 및 프레젠테이션 섹션에서 이용 가능하며, 이벤트 후 90일 동안 보관됩니다.
ESSA Pharma (NASDAQ: EPIX), une entreprise pharmaceutique en phase clinique axée sur le développement de nouvelles thérapies pour le traitement du cancer de la prostate, a annoncé sa participation à la Conférence Mondiale sur la Santé Cantor 2024. L'entreprise présentera le 18 septembre 2024 à 9h10 ET à New York, NY.
Les principaux dirigeants participant à une discussion informelle incluent David R. Parkinson (Président et PDG), Peter Virsik (COO et EVP) et David S. Wood (CFO). Un webinaire en direct de l'événement sera disponible sur le site Web d'ESSA dans la section Investisseurs/Événements et Présentations, et sera archivé pendant 90 jours après l'événement.
ESSA Pharma (NASDAQ: EPIX), ein pharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung neuartiger Therapien zur Behandlung von Prostatakrebs konzentriert, hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference angekündigt. Das Unternehmen wird am 18. September 2024 um 9:10 Uhr ET in New York, NY präsentieren.
Zu den leitenden Angestellten, die an einem informellen Gespräch teilnehmen, gehören David R. Parkinson (Präsident und CEO), Peter Virsik (COO und EVP) und David S. Wood (CFO). Eine Live-Übertragung der Veranstaltung wird auf der Webseite von ESSA im Bereich Investoren/Veranstaltungen und Präsentationen verfügbar sein und wird 90 Tage nach der Veranstaltung archiviert bleiben.
- None.
- None.
David R. Parkinson, President and Chief Executive Officer, Peter Virsik, Chief Operating Officer and Executive Vice President, and David S. Wood, Chief Financial Officer, will participate in a fireside chat.
A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essaphrma.com, and follow us on X and LinkedIn.
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-2024-cantor-global-healthcare-conference-302244410.html
SOURCE ESSA Pharma Inc
FAQ
When is ESSA Pharma (EPIX) presenting at the 2024 Cantor Global Healthcare Conference?
Who will be representing ESSA Pharma (EPIX) at the 2024 Cantor Global Healthcare Conference?
How can I watch ESSA Pharma's (EPIX) presentation at the 2024 Cantor Global Healthcare Conference?
What is the main focus of ESSA Pharma (EPIX)?
